Automated External Defibrillators Market is expected to reach US$ 2,207.94 million by 2030

Publisher: The Insight Partners

Fully Automated External Defibrillators Segment to Hold Significant Share of Automated External Defibrillators Market During 2022–2030

According to our latest study on "Automated External Defibrillators Market Forecast to 2030 – Global Analysis – by Type and End User," the market was valued at US$ 1,556.21 million in 2022 and is expected to reach US$ 2,207.94 million by 2030; it is estimated to record a CAGR of 4.5% from 2022 to 2030. The report emphasizes the key factors driving the market and prominent players with their developments. The growth of the market is attributed to the increasing prevalence of cardiovascular diseases and rising training and awareness programs on automated external defibrillators. However, performance issues related to automated external defibrillators are hindering the market growth.

A lay responder can use a fully automatic external defibrillator (FAED) to treat someone who has gone into cardiac arrest. In FAEDs, the user does not need to press any buttons to provide the shock; the device analyzes itself, and if a shock is required, the device administers it without the need for anyone to press a button. The user activates the FAED by pressing a button or opening the lid. The user unfolds the pads and places them on the patient as directed by the illustrations on the pads. The FAED analyzes the patient's heart rhythm once the pads are in place to see if a shock is required. If a shock is required, the FAED notifies and gives a shock to the patient without the help of any individual to push the shock button.

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00018785

By end user, the automated external defibrillators market is segmented into hospitals & clinics, homecare, and others. In 2022, the hospitals & clinics segment held the largest market share, and the homecare segment is estimated to record the fastest CAGR of 5% from 2022 to 2030. Hospitals and clinics are the largest entities that have all the facilities available. Hospitals and clinics also provide several diagnostics and treatment facilities that can be reimbursed in case of insurance claims. Hospitals have all the required equipment and instruments, such as defibrillators. Due to the development of healthcare facilities, hospitals are upgraded with modernized equipment and are integrated with artificial intelligence. These developments assist in inter-department communication and perform auto procedures with precision. Hospitals have general doctors, specialists, and other medical professionals who provide better healthcare services. The rise in cardiac arrest cases drives the market for the hospitals & clinics segment. Moreover, the rise in the number of cardiac implant procedures and the availability of reimbursements in developed markets are driving the market growth for the hospitals & clinics segment.

Based on geography, the microcarriers market is categorized into North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, Japan, Australia, India, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa), and South & Central America (Argentina, Brazil, and Rest of South & Central America).

Shenzhen Mindray Bio-Medical Electronics Co Ltd, Stryker Corp, BPL Medical Technologies Pvt Ltd, Schiller AG, Mediana Co Ltd, Nihon Kohden Corp, Asahi Kasei Corp, CU Medical Systems Inc, Progetti SRL, and Koninklijke Philips NV are among the leading companies functioning in the automated external defibrillator market.

Technological Advancements to Fuel Automated External Defibrillator Market During Forecast Period

There is a rise in technological advancements and increased investments in defibrillators by private players. In August 2022, Asahi Kasei (ZOLL) Medical Corporation introduced the Asahi Kasei (ZOLL) AED 4 defibrillator with integrated Wi-Fi connectivity for remote monitoring and data management, enhancing ease of use and maintenance. Similarly, in May 2023, Boston Scientific launched the EMPOWER External Defibrillator with smart features, including mobile app connectivity, patient education resources, and remote monitoring capabilities. In September 2019, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. launched the BeneHeart C Series of AEDs with intelligent operations and faster shock delivery to achieve better recovery outcomes for sudden cardiac arrest (SCA). The product range is available in fully automatic and semi-automatic versions that offer up to 360 Joules and are integrated with unique ResQNavi technology. The BeneHeart C AEDs deliver the first shock in less than 8 seconds. The series is made available in Europe. Furthermore, in March 2021, the Government House in Australia launched the St. John-branded public access defibrillator, an automated external defibrillator (AED). This AED was a joint venture between St John Ambulance Australia and Asahi Kasei (ZOLL Medical Australia). Thus, the launch of new products due to the rise in technological advancements is leading to significant future trends in the automated external defibrillator market.  

Contact Us

Contact Us: The Insight Partners

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com